title: Is the variant c.422+90G → A in intron 4 of indoleamine 2, 3 -dioxygenase (IDO) gene related to age related cataracts?
abstract: OBJECTIVE
  To screen for sequence variations in the IDO gene that encodes indoleamine 2, 3- dioxygenase (IDO), the first rate limiting enzyme involved in the tryptophan catabolism which results in the production of UV filters playing a role in the maintenance of lens transparency.
  
  
  METHODS
  We conducted a case-control study to screen for sequence changes in the IDO gene and associated demographic risk factors in patients with nuclear (NC-110), cortical (CC-110) and Posterior sub capsular (PSC-111) cataracts in comparison to normal controls (210) from Hyderabad, India.
  
  
  RESULTS
  Among the cataract types studied high risk was observed for CC and PSC types in female patients, individuals with low body mass index and smoking habit. Cataract development had early onset more frequently in cases of PSC followed by CC and NC. Screening by single strand conformation polymorphism (SSCP) revealed mobility shifts in 6 of the 331 patient (3 with NC and 3 with PSC) samples which upon sequencing confirmed the presence of G → A transition (c.422+90G → A; rs4613984) in the intron downstream to exon 4 of IDO which was further tested by RFLP analysis using the HhaI restriction enzyme. Of the 6 patients, one with nuclear cataract showed homozygosity and the remaining five showed heterozygosity for the substitution. None of the control samples showed this variation.
  
  
  CONCLUSIONS
  It is possible that the substitution c.422+90G → A; rs4613984 in an intron downstream to exon 4 of IDO may be related with cataract formation among the aged.
authors: Department of Genetics, Osmania University, Hyderabad, India.
authors: M
authors: M
authors: Mamata
authors: G
authors: G
authors: Sridhar
authors: K Ravi Kumar
authors: KR
authors: Reddy
authors: T
authors: T
authors: Nagaraju
authors: T
authors: T
authors: Padma
references: J Clin Invest. 2007 May;117(5):1147-54
references: 17476344
references: JAMA. 2003 Oct 15;290(15):2057-60
references: 14559961
references: Arch Ophthalmol. 1997 Oct;115(10):1296-303
references: 9338677
references: Exp Eye Res. 2007 Aug;85(2):219-25
references: 17574241
references: J Biol Chem. 1999 Nov 12;274(46):32547-50
references: 10551806
references: Ophthalmology. 1992 Apr;99(4):546-52
references: 1584573
references: Free Radic Biol Med. 2008 Mar 15;44(6):1108-19
references: 18206985
references: Invest Ophthalmol Vis Sci. 2004 Mar;45(3):879-83
references: 14985305
references: Exp Eye Res. 1989 Aug;49(2):189-94
references: 2767167
references: Ophthalmology. 1997 Apr;104(4):581-8
references: 9111249
references: Eye (Lond). 1987;1 ( Pt 5):537-41
references: 3328701
references: Proteomics. 2002 May;2(5):551-60
references: 11987129
references: JAMA. 1992 Aug 26;268(8):994-8
references: 1501325
references: Eye (Lond). 1989;3 ( Pt 4):379-84
references: 2606211
references: Bull World Health Organ. 2001;79(3):249-56
references: 11285671
references: Nat Genet. 1998 Jun;19(2):167-70
references: 9620774
references: Exp Eye Res. 2005 May;80(5):709-25
references: 15862178
references: FASEB J. 1991 Aug;5(11):2516-22
references: 1907934
references: JAMA. 2000 Aug 9;284(6):713-6
references: 10927779
references: Hum Genet. 1994 Feb;93(2):201-3
references: 8112747
references: Arch Ophthalmol. 1988 Mar;106(3):330-4
references: 3345149
references: Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3237-44
references: 10586948
references: Mol Vis. 2009 Dec 16;15:2780-8
references: 20019876
references: Ophthalmic Physiol Opt. 1999 Jul;19(4):300-5
references: 10645386
references: Br J Ophthalmol. 1995 Mar;79(3):199-200
references: 7703192
references: Am J Ophthalmol. 1999 Oct;128(4):446-65
references: 10577586
references: J Biol Chem. 2002 Feb 15;277(7):4867-73
references: 11726659
references: Am J Epidemiol. 2000 Mar 1;151(5):497-504
references: 10707918
references: Exp Eye Res. 2001 Mar;72(3):271-7
references: 11180976
references: Free Radic Biol Med. 2004 Nov 1;37(9):1479-89
references: 15454288
references: J Proteome Res. 2007 Oct;6(10):3935-43
references: 17824632
references: Br J Ophthalmol. 1982 Jan;66(1):35-42
references: 7055541
references: FASEB J. 1989 Apr;3(6):1741-6
references: 2703107
references: Pharmacogenet Genomics. 2009 Jun;19(6):464-76
references: 19514129
references: Arch Ophthalmol. 1997 Jan;115(1):105-11
references: 9006434
references: Nucleic Acids Res. 1991 Oct 11;19(19):5444
references: 1681511
references: Am J Prev Med. 1993 Jan-Feb;9(1):65-6
references: 8439443
references: Biochemistry. 2006 Feb 14;45(6):1950-60
references: 16460042
references: Arch Ophthalmol. 1997 Sep;115(9):1113-8
references: 9298050
references: J Reprod Immunol. 2011 Jan;88(1):42-7
references: 21030093
references: Autoimmunity. 2008 Feb;41(1):92-9
references: 18176870
references: Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4091-8
references: 15505060